Related Experiment Video
Updated: Aug 15, 2026
A Novel Microsurgical Model for Heterotopic, En Bloc Chest Wall, Thymus, and Heart Transplantation in Mice
Published on: January 23, 2016
Developments in mechanical support as a bridge to cardiac transplant
1Division of Cardiac Surgery, Ottawa Heart Institute, Ottawa, Ontario. phendry@ottawaheart.ca
Abstract:
With the increasing incidence of congestive heart failure and limited numbers of donor hearts for transplantation, mechanical circulatory support devices are being used with greater frequency in Canada. The indications for device use, types of available pumps and centres performing these procedures are presented. A review of the results of use of these devices in Canada indicates that they may be a reasonable alternative for patients who might otherwise die without intervention. The cost implications of more widespread use of these pumps are not insignificant and must be compared with other life-saving technologies.
Insights
Mechanical circulatory support devices offer a viable alternative for Canadians with congestive heart failure due to donor heart scarcity. Their use shows promise as a life-saving intervention, though cost-effectiveness requires careful consideration against other treatments.
Area of Science:
- Cardiology
- Medical Devices
- Transplantation Medicine
Background:
- Increasing incidence of congestive heart failure necessitates advanced treatment options.
- Limited availability of donor hearts restricts heart transplantation success.
- Mechanical circulatory support (MCS) devices are gaining prominence in cardiac care.
Purpose of the Study:
- To present indications for MCS device use in Canada.
- To detail available MCS pump types and performing centers.
- To review the outcomes of MCS device implantation in Canadian patients.
Main Methods:
- Review of current practices and outcomes for MCS devices in Canada.
- Analysis of indications, device types, and procedural centers.
- Evaluation of the effectiveness and cost implications of MCS devices.
Main Results:
- MCS devices are increasingly utilized in Canada for heart failure management.
- These devices represent a potentially life-saving option for patients ineligible for transplantation.
- The study outlines specific indications, pump technologies, and Canadian centers involved.
Conclusions:
- Mechanical circulatory support devices are a reasonable alternative for patients with severe heart failure in Canada.
- Further analysis is needed to compare the cost-effectiveness of MCS devices with other life-saving medical technologies.
- Widespread adoption of these devices necessitates a thorough economic evaluation.
